The conception is not new. Compani...

The conception is not new. Companies comparing performance and practices and then mutually identifying the best solutions to frequent operational challenges has been a part of business for years. What is different is that this is happening in the biopharmaceutical industry, which, until lately has been primarily focused in succession filling the pipeline and forward improving the manufacturing processes themselves. This focus was not misguided- the biggest challenge facing biopharmaceutical companies until the last five years was convincing everyone that they were legitimate players that can cause to grow ...